RS
KURA icon

R Squared’s Kura Oncology KURA Stock Holding History

R Squared’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,620
Closed -$14.1K – 928
2024
Q4 		$14.1K Buy
+1,620
New +$23.3K 0.01% 1038

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

R Squared's KURA Position: Q1 2025 in Review

R Squared sold out of Kura Oncology (KURA) in Q1 2025, closing a stake of 1,620 shares — an estimated $14.1K sold.

R Squared first reported a position in KURA in Q4 2024 and held it in 1 quarter. The position peaked at $14.1K in Q4 2024. 183 funds tracked by Wall St. Rank hold KURA as of Q1 2025.

  • R Squared reported no remaining Kura Oncology position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 1,620 Kura Oncology shares in Q1 2025, an estimated $14.1K.
  • R Squared first reported a position in Kura Oncology in Q4 2024 and held it in 1 quarter.
  • R Squared's Kura Oncology position peaked at $14.1K in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.